Akhavanrezayat Amir, Hien Doan Luong, Pham Brandon H, Nguyen Huy Vu, Tuong Ngoc Than Trong, Al-Moujahed Ahmad, Uludag Gunay, Karkhur Samendra, Doan Huy Luong, Nguyen Quan Dong
Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Pham Ngoc Thach University of Medicine, Saigon, Viet Nam.
Am J Ophthalmol Case Rep. 2020 Sep 18;20:100934. doi: 10.1016/j.ajoc.2020.100934. eCollection 2020 Dec.
To report a case of impending central retinal vein occlusion (CRVO) associated with idiopathic cutaneous leukocytoclastic vasculitis (LCV) that demonstrated significant resolution following treatment with intravenous (IV) methylprednisolone.
A 27-year-old man presented to a tertiary Uveitis Clinic with a five-day history of blurry vision in the right eye (OD). He had a history of a purpuric rash and arthralgias five years ago and a biopsy-confirmed diagnosis of LCV controlled with colchicine two years ago in India. Recently, he presented with a recurrent rash and severe abdominal pain. After being evaluated by rheumatology and gastroenterology, he was placed on treatment and high dose oral prednisone, which improved his skin and gastrointestinal symptoms. At the first ophthalmic exam, his systemic findings included lower extremity purpura. His best-corrected visual acuity (BCVA) was 20/20 in both eyes (OU). Slit-lamp examination revealed no cells or flare in OU. Dilated fundus exam showed mild enlarged, tortuous veins, optic nerve hemorrhage, and intraretinal hemorrhages temporal to the macula in OD. Spectral-domain optical coherence tomography (SD-OCT) demonstrated multiple hyper-reflective, plaque-like lesions involving the inner nuclear layer, consistent with paracentral acute middle maculopathy (PAMM). The patient was diagnosed with impending central retinal vein occlusion (CRVO) in OD. Laboratory evaluations were unremarkable. Aspirin was initially started for the patient but was later held due to the worsening of retinal hemorrhage and retinal vein tortuosity at the one-week follow-up. The patient then received three doses of intravenous methylprednisolone, followed by systemic oral prednisone and mycophenolate mofetil. One month later, retinal hemorrhages, venous stasis, and skin manifestations resolved.
Ocular involvement in LCV is rare and may present with different manifestations. The index case is the first report of impending CRVO in a patient with idiopathic LCV and without any other known risk factors for CRVO. Our report not only describes the unique course of LCV-related ocular involvement, but also introduces and underscores a potentially effective therapeutic plan.
报告一例即将发生的视网膜中央静脉阻塞(CRVO)合并特发性皮肤白细胞破碎性血管炎(LCV)的病例,该病例经静脉注射甲基强的松龙治疗后症状明显缓解。
一名27岁男性前往一家三级葡萄膜炎诊所就诊,右眼视力模糊已有五天病史。他五年前有紫癜性皮疹和关节痛病史,两年前在印度经活检确诊为LCV,一直用秋水仙碱控制病情。最近,他再次出现皮疹和严重腹痛。在接受风湿病学和胃肠病学评估后,他开始接受治疗并服用高剂量口服泼尼松,皮肤和胃肠道症状有所改善。首次眼科检查时,他的全身检查结果包括下肢紫癜。他双眼的最佳矫正视力(BCVA)均为20/20。裂隙灯检查显示双眼均无细胞或闪光。散瞳眼底检查显示右眼静脉轻度扩张、迂曲,视神经出血,黄斑颞侧视网膜内出血。光谱域光学相干断层扫描(SD-OCT)显示多个高反射性、斑块状病变累及内核层,符合中心旁急性黄斑病变(PAMM)。该患者被诊断为右眼即将发生视网膜中央静脉阻塞(CRVO)。实验室检查无异常。患者最初开始服用阿司匹林,但在一周后的随访中,由于视网膜出血和视网膜静脉迂曲加重而停药。随后患者接受了三剂静脉注射甲基强的松龙,随后改为全身口服泼尼松和霉酚酸酯。一个月后,视网膜出血、静脉淤滞和皮肤表现均消失。
LCV累及眼部罕见,可能有不同表现。该病例是首例特发性LCV患者且无其他已知CRVO危险因素而即将发生CRVO的报告。我们的报告不仅描述了LCV相关眼部受累的独特病程,还介绍并强调了一种潜在有效的治疗方案。